Suicide risk during antidepressent treatment

American Journal of Psychiatry

Volumn 163, Issue 1, 2006, Pages 41-47

  Simon, Gregory E ^a   Savarino, James ^b   Operskalski, Belinda ^b   Wang, Philip S ^b  

^a CENTER FOR HEALTH STUDIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOSULEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CHILD; DEPRESSION; FEMALE; FOOD AND DRUG ADMINISTRATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDE; SUICIDE ATTEMPT; COMPARATIVE STUDY; DEATH CERTIFICATE; DRUG UTILIZATION; FOLLOW UP; HEALTH INSURANCE; MEDICAL RECORD; MIDDLE AGED; MORTALITY; PRESCRIPTION; PSYCHOLOGICAL ASPECT; RISK FACTOR; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CAUSE OF DEATH; DEATH CERTIFICATES; DEPRESSIVE DISORDER; DRUG UTILIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PREPAID HEALTH PLANS; PRESCRIPTIONS, DRUG; RISK FACTORS; SUICIDE; SUICIDE, ATTEMPTED; UNITED STATES;

EID: 30044432889     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.163.1.41     Document Type: Article

References (34)

1. US Food and Drug Administration, Center for Drug Evaluation and Research: FDA public health advisory: worsening depression and suicidality in patients being treated with antidepressant medications, March 22, 2004. http://www.fda.gov/cder/drug/antidepressants/AntidepressanstPHA.htm
2. Hampton T: Suicide caution stamped on antidepressants. JAMA 2004; 291:2060-2061
3. Waknine Y: Medscape alert: antidepressants may cause depression and suicidality, March 22, 2004. http:// www.medscape.com/viewarticle/472364
4. Harris G: Regulators want antidepressants to list warning. New York Times, March 23, 2004, p A1
5. Neergaard L: FDA issues suicide caution for antidepressant use, March 22, 2004. http://www.sfgate.com/cgi-bin/article.cgi7f=/news/a/2004/03/22/ national1040EST0531.DTL
6. UK Medicines and Health Care Products Regulatory Agency: Department of Health press release: Seroxat must not be used for treatment of children, June 10, 2003. http://www.mhra.gov.uk/news/2003/seroxat10603.pdf
7. Mitka M: FDA alert on antidepressants for youth (news). JAMA 2003; 290:2534
8. Moynihan R: FDA advisory panel calls for suicide warnings over new antidepressants (news). BMJ 2004; 328:303
9. Mayer-Gross W, Slater E, Roth M: Clinical Psychiatry. London, Cassell, 1960, p 231
10. US Food and Drug Administration, Psychopharmacologic Drugs Advisory Committee and Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee: Slides, Feb 2, 2004. www.fda.gov/ohrms/dockets/ac/04/slides/4006s1. htm
11. Khan A, Khan S, Kolts R, Brown WA: Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003; 160:790-792
12. Storosum JG, van Zwieten BJ, van den Brink W, Gersons BPR, Broekmans AW: Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 2001; 158:1271-1275
13. Goldney RD: Suicide risk in placebo-controlled studies (letter). Am J Psychiatry 2002; 159:680-681
14. Shaffer D: Suicide and related problems in adolescence, Feb 22, 2004. www.fda.gov/ohrms/dockets/ac/04/slides/ 4006S1_03_Shaffer_files/outline.htm
15. Jick H, Kaye J, Jick S: Antidepressants and the risk of suicidal behaviors. JAMA 2004; 292:338-343
16. Simon G, Von Korff M, Barlow W, Pabiniak C, Wagner E: Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 1996; 49:1067-1073
17. Saunders K, Stergachis A, Von Korff M: Group Health Cooperative of Puget Sound, in Pharmacoepidemiology, 2nd ed. Edited by Strom B. New York, John Wiley & Sons, 1994, pp 171-184
18. Simon G, Von Korff M: Suicide mortality among patients treated for depression in an insured population. Am J Epidemiol 1998; 147:155-160
19. Jick S, Dean A, Jick H: Antidepressants and suicide. BMJ 1995; 310:215-218
20. Bostwick JM, Pankratz VS: Affective disorders and suicide risk: a reexamination. Am J Psychiatry 2000; 157:1925-1932
21. Simon G, Von Korff M, Rutter C, Peterson D: Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry 2001; 58:395-401
22. Teicher M, Glod CA, Cole JO: Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf 1993; 8:186-212
23. Jureidini J, Doecke C, Mansfield P, Haby M, Menkes D, Tonkin A: Efficacy and safety of antidepressants for children and adolescents. BMJ 2004; 328:879-883
24. Vitiello B, Swedo S: Antidepressant medications in children. N Engl J Med 2004; 350:1489-1491
25. National Committee for Quality Assurance, Health Plan Employer Data and Information Set (HEDIS): The State of Health Care Quality, 2002. http://www.ncqa.org/sohc2002/ sohc_2002_amm.html
26. Monk M: Epidemiology of suicide. Epidemiol Rev 1987; 9:51-69
27. Moscicki E: Epidemiology of suicidal behavior. Suicide Life Threat Behav 1995; 25:22-35
28. Brent D, Perper JA, Allman CJ: Alcohol, firearms, and suicide among youth. JAMA 1987; 257:3369-3372
29. Pfeffer C: Pediatric depression and its treatment, Feb 2, 2004. www.fda.gov/ohrms/dockets/ac/04/slides/ 4006S1_02_Pfeffer_files/outline.htm
30. Saunders K, Simon G, Bush T, Grothaus L: Assessing the accuracy of computerized pharmacy refill data for monitoring antidepressant treatment: a comparison of automated and self-report data. J Clin Epidemiol 1998; 51:883-890
31. Wang P, Berglund P, Kessler R: Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med 2000; 15:284-292
32. Young A, Klapp R, Sherbourne C, Wells K: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001; 58:55-61
33. Simon G, Von Korff M, Rutter C, Wagner E: A randomized trial of monitoring, feedback, and management of care by telephone to improve depression treatment in primary care. BMJ 2000; 320:550-554
34. Hunkeler EM, Meresman JF, Hargreaves WA, Fireman B, Berman WH, Kirsch AJ, Groebe J, Hurt SW, Braden P, Getzell M, Feigenbaum PA, Peng T, Salzer M: Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med 2000; 9:700-708